LivingGLP1
Study S000126

Magnetic Compression Anastomosis in Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes (MAGvMED Study)

Registration

Registration
NCT07317115
Acronym
MAGvMED
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
RECRUITING
Enrollment
20
Start
2026-03-18
Primary completion
2027-06
Lead sponsor
GT Metabolic Solutions, Inc.
Conditions
Obesity (Disorder); Obesity & Overweight; Type 2 Diabetes (T2DM)
Interventions
DEVICE:Magnet System; DRUG:Semaglutide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Functional improvement of T2D: HbA1c [Day 360]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.